The dopamine D2 receptor (DRD2) gene–a genetic risk factor in heavy smoking?
- 1 October 2000
- journal article
- Published by Wiley in Addiction Biology
- Vol. 5 (4) , 429-436
- https://doi.org/10.1111/j.1369-1600.2000.tb00212.x
Abstract
Indications of a genetic predisposition to nicotine dependence have been derived from numerous epidemiological data and from individual genetic studies suggesting the involvement of the dopaminergic D2 receptor. Previous association studies defined the TaqlA polymorphism as a risk factor for addiction, in particular for alcoholism and tobacco dependence. Results of investigations into this polymorphism in 110 severely addicted smokers and a control group of 60 population-matched German non-smokers did not support these findings. However, our results indicate an association between the DRD2-Fokl-1 allele and the onset and intensity of smoking.Keywords
This publication has 49 references indexed in Scilit:
- The DRD2 A1 allele: a behavioural genetic risk factor in hepatitis C infection of persistent drug abusersAddiction Biology, 1999
- Genetic and environmental contributions to smokingAddiction, 1997
- Molecular and Cellular Aspects of Nicotine AbusePublished by Elsevier ,1996
- Society for Research on Nicotine and TobaccoAddiction, 1996
- Society for Research on Nicotine and TobaccoAddiction, 1996
- D2 dopamine receptor gene and cigarette smoking: A reward gene?Medical Hypotheses, 1994
- The Dopamine D2 Receptor (DRD2) as a Major Gene in Obesity and HeightBiochemical Medicine and Metabolic Biology, 1993
- The D2 dopamine receptor gene: A review of association studies in alcoholismBehavior Genetics, 1993
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991
- The dopamine D2 receptor gene and alcoholismPublished by American Medical Association (AMA) ,1991